Streetbeat News

Price Targets

TTD

Truist Securities analyst Youssef Squali has reiterated a Buy rating on Trade Desk (NASDAQ:TTD) and maintained an $80 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 6:04 pm

REGN

Truist Securities analyst Robyn Karnauskas has reiterated a Buy rating on Regeneron Pharmaceuticals (NASDAQ:REGN) and maintained a price target of $1045.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 6:02 pm

ALLK

Over the last 3 months, 4 Wall Street analysts have provided ratings on Allakos (NASDAQ:ALLK), with 3 being somewhat bullish and 1 somewhat bearish. The average 12-month price target for Allakos is $8.12, ranging from a high of $11.00 to a low of $1.50. This target has increased by 20.3% from the previous target of $6.75. Analyst ratings are updated quarterly and are based on company performance, financial analysis, and insider information.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 6:00 pm

OPRT

Oportun Financial (NASDAQ:OPRT) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, 2 indifferent, and no bearish ratings. The average price target among these analysts is $7.5, which represents a significant upside from the current price of $2.25. However, this target has decreased by 2.22% from the previous target of $7.67. Analysts' ratings are based on various data sources, including company calls, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 6:00 pm

AXL

BofA Securities analyst John Murphy downgraded American Axle & Manufacturing Holdings Inc (NYSE:AXL) from Neutral to Underperform and cut the price target from $9 to $8. Murphy cites no visible positive catalysts for AXL until well into 2024, potential volume pressure in late 2023 and early 2024, and persistent plant-level issues. The recent UAW strike is expected to impact Q4 revenue and EBITDA significantly. Despite the current outlook, Murphy acknowledges American Axle's history of solid execution and suggests potential investor interest mid-2024.

Portfolio Pulse from Priya Nigam

November 28, 2023 | 6:00 pm

CHRS

Over the past quarter, Coherus BioSciences (NASDAQ:CHRS) received 6 analyst ratings, with 4 being bullish and 2 somewhat bullish. There were no indifferent, somewhat bearish, or bearish ratings. The average price target is $13.83, which is significantly higher than the current price of $1.995. This target suggests a substantial upside but is a 1.21% decrease from the previous target of $14.00. Analysts derive their ratings from various sources, including company calls, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 6:00 pm

NHI

Over the last quarter, National Health Investors (NYSE:NHI) received 4 indifferent analyst ratings with no change in the average 12-month price target of $54.00. The high target is $55.00 and the low target is $52.00. These ratings suggest a neutral consensus among analysts regarding NHI's stock performance.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 6:00 pm

SYF

Analysts have provided mixed ratings for Synchrony Financial (NYSE:SYF) in the last quarter, with 1 bullish, 4 somewhat bullish, 3 indifferent, and 2 somewhat bearish ratings. The average 12-month price target for SYF is $34.9, representing a 7.23% decrease from the previous target of $37.62. Ratings are based on information from company events, financial statements, and insider conversations.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 6:00 pm

MUR

Truist Securities analyst Neal Dingmann has reiterated a Buy rating on Murphy Oil (NYSE:MUR) with a maintained price target of $57.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 6:00 pm

FCN

Truist Securities analyst Tobey Sommer has reiterated a Buy rating on FTI Consulting (NYSE:FCN) and maintained a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 5:58 pm